| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | PRAMEF10 PRAMEF9 FBXO3 BTRC PRAMEF11 PRAMEF33 PRAMEF15 PRAMEF4 PRAMEF27 | 1.02e-07 | 82 | 194 | 9 | GO:1990756 |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | PRAMEF10 PRAMEF9 FBXO3 BTRC PRAMEF11 PRAMEF33 PRAMEF15 PRAMEF4 PRAMEF27 | 3.66e-07 | 95 | 194 | 9 | GO:0140767 |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.52e-05 | 55 | 194 | 6 | GO:0042974 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | PRAMEF10 PRAMEF9 PRAMEF11 PRAMEF33 PRAMEF15 PRAMEF4 PRAMEF27 | 2.62e-07 | 47 | 196 | 7 | GO:0031462 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | PRAMEF10 PRAMEF9 FBXO3 BTRC PRAMEF11 CUL4B PRAMEF33 PRAMEF15 PRAMEF4 PRAMEF27 | 3.31e-05 | 212 | 196 | 10 | GO:0031461 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | KANSL1L PRAMEF10 PRAMEF9 DCUN1D4 ATXN7L3 FBXO3 CIAO1 MED17 HSPA8 BTRC PRAMEF11 CUL4B PRAMEF33 RARS1 RTCB PRAMEF15 LARS1 TSEN54 PRAMEF4 TRAPPC8 MTOR PRAMEF27 QRSL1 | 4.35e-05 | 972 | 196 | 23 | GO:0140535 |
| GeneOntologyCellularComponent | ubiquitin ligase complex | PRAMEF10 PRAMEF9 DCUN1D4 FBXO3 MED17 BTRC PRAMEF11 CUL4B PRAMEF33 PRAMEF15 PRAMEF4 PRAMEF27 | 1.29e-04 | 352 | 196 | 12 | GO:0000151 |
| MousePheno | increased male germ cell apoptosis | SETX PRAMEF10 LRRIQ1 TDRD6 PRAMEF11 PRAMEF33 PRAMEF15 PRAMEF4 PRAMEF27 ZMYM3 MYBL1 | 4.62e-06 | 189 | 146 | 11 | MP:0014052 |
| MousePheno | abnormal spermatogonia proliferation | 8.84e-06 | 47 | 146 | 6 | MP:0002685 | |
| MousePheno | abnormal male germ cell apoptosis | SETX PRAMEF10 LRRIQ1 TDRD6 PRAMEF11 PRAMEF33 PRAMEF15 PRAMEF4 PRAMEF27 ZMYM3 MYBL1 | 3.72e-05 | 236 | 146 | 11 | MP:0008280 |
| MousePheno | abnormal male germ cell physiology | SETX PRAMEF10 LRRIQ1 TDRD6 PRAMEF11 PRAMEF33 PRAMEF15 PRAMEF4 PRAMEF27 ZMYM3 MYBL1 | 5.04e-05 | 244 | 146 | 11 | MP:0020362 |
| Domain | Spectrin_repeat | 2.99e-10 | 29 | 186 | 8 | IPR002017 | |
| Domain | SPEC | 7.13e-10 | 32 | 186 | 8 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.13e-10 | 32 | 186 | 8 | IPR018159 | |
| Domain | Spectrin | 7.89e-08 | 23 | 186 | 6 | PF00435 | |
| Domain | ACTININ_2 | 7.89e-08 | 23 | 186 | 6 | PS00020 | |
| Domain | ACTININ_1 | 7.89e-08 | 23 | 186 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.89e-08 | 23 | 186 | 6 | IPR001589 | |
| Domain | PRAME_family | 9.64e-07 | 19 | 186 | 5 | IPR026271 | |
| Domain | CH | 3.71e-06 | 65 | 186 | 7 | SM00033 | |
| Domain | CH | 6.13e-06 | 70 | 186 | 7 | PF00307 | |
| Domain | - | 6.74e-06 | 71 | 186 | 7 | 1.10.418.10 | |
| Domain | CH | 8.12e-06 | 73 | 186 | 7 | PS50021 | |
| Domain | WD40_repeat_dom | NBEAL1 COPB2 NWD2 CIAO1 WDR35 PHIP BTRC BRWD1 WDR48 UBR4 NOL11 SEC31B TBC1D31 | 9.16e-06 | 297 | 186 | 13 | IPR017986 |
| Domain | CH-domain | 9.73e-06 | 75 | 186 | 7 | IPR001715 | |
| Domain | - | 1.90e-05 | 6 | 186 | 3 | 3.90.1290.10 | |
| Domain | Plectin | 3.30e-05 | 7 | 186 | 3 | PF00681 | |
| Domain | Plectin_repeat | 3.30e-05 | 7 | 186 | 3 | IPR001101 | |
| Domain | PLEC | 3.30e-05 | 7 | 186 | 3 | SM00250 | |
| Domain | WD40 | NBEAL1 COPB2 NWD2 CIAO1 WDR35 PHIP BTRC BRWD1 WDR48 SEC31B TBC1D31 | 8.08e-05 | 268 | 186 | 11 | SM00320 |
| Domain | WD40_repeat | NBEAL1 COPB2 NWD2 CIAO1 WDR35 PHIP BTRC BRWD1 WDR48 SEC31B TBC1D31 | 9.22e-05 | 272 | 186 | 11 | IPR001680 |
| Domain | PH_dom-like | NBEAL1 SPTBN1 DGKH SPTBN5 PHLDB1 GRK2 OSBPL9 OSBPL10 PLEKHH2 RASA3 RGS3 NECAP2 ROCK1 PLCE1 | 9.76e-05 | 426 | 186 | 14 | IPR011993 |
| Domain | PH | SPTBN1 DGKH SPTBN5 PHLDB1 GRK2 OSBPL9 OSBPL10 PLEKHH2 RASA3 ROCK1 | 1.03e-04 | 229 | 186 | 10 | PF00169 |
| Domain | WD_REPEATS_1 | NBEAL1 COPB2 NWD2 CIAO1 WDR35 PHIP BTRC BRWD1 WDR48 SEC31B TBC1D31 | 1.12e-04 | 278 | 186 | 11 | PS00678 |
| Domain | WD_REPEATS_2 | NBEAL1 COPB2 NWD2 CIAO1 WDR35 PHIP BTRC BRWD1 WDR48 SEC31B TBC1D31 | 1.15e-04 | 279 | 186 | 11 | PS50082 |
| Domain | WD_REPEATS_REGION | NBEAL1 COPB2 NWD2 CIAO1 WDR35 PHIP BTRC BRWD1 WDR48 SEC31B TBC1D31 | 1.15e-04 | 279 | 186 | 11 | PS50294 |
| Domain | - | NBEAL1 COPB2 NWD2 CIAO1 WDR35 PHIP BTRC BRWD1 WDR48 NOL11 SEC31B TBC1D31 | 1.32e-04 | 333 | 186 | 12 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | NBEAL1 COPB2 NWD2 CIAO1 WDR35 PHIP BTRC BRWD1 WDR48 NOL11 SEC31B TBC1D31 | 1.40e-04 | 335 | 186 | 12 | IPR015943 |
| Domain | - | SPTBN1 DGKH SPTBN5 PHLDB1 GRK2 OSBPL9 OSBPL10 PLEKHH2 RASA3 RGS3 NECAP2 ROCK1 PLCE1 | 1.55e-04 | 391 | 186 | 13 | 2.30.29.30 |
| Domain | ARM-type_fold | NBEAL1 USP9X UNC45A ITPR2 PIK3C3 CLTC ULK4 FMNL1 KPNA1 UBR4 HEATR5A MTOR | 1.56e-04 | 339 | 186 | 12 | IPR016024 |
| Domain | WD40_repeat_CS | 2.42e-04 | 164 | 186 | 8 | IPR019775 | |
| Domain | WD40 | NBEAL1 COPB2 CIAO1 WDR35 PHIP BTRC BRWD1 WDR48 SEC31B TBC1D31 | 2.79e-04 | 259 | 186 | 10 | PF00400 |
| Domain | DUF1977 | 2.94e-04 | 3 | 186 | 2 | PF09320 | |
| Domain | DUF1977_DnaJ-like | 2.94e-04 | 3 | 186 | 2 | IPR015399 | |
| Domain | PH | SPTBN1 DGKH SPTBN5 PHLDB1 GRK2 OSBPL9 OSBPL10 PLEKHH2 RASA3 ROCK1 | 4.88e-04 | 278 | 186 | 10 | SM00233 |
| Domain | PH_DOMAIN | SPTBN1 DGKH SPTBN5 PHLDB1 GRK2 OSBPL9 OSBPL10 PLEKHH2 RASA3 ROCK1 | 5.02e-04 | 279 | 186 | 10 | PS50003 |
| Domain | PH_domain | SPTBN1 DGKH SPTBN5 PHLDB1 GRK2 OSBPL9 OSBPL10 PLEKHH2 RASA3 ROCK1 | 5.16e-04 | 280 | 186 | 10 | IPR001849 |
| Domain | TPR-like_helical_dom | 5.61e-04 | 233 | 186 | 9 | IPR011990 | |
| Domain | KASH | 5.84e-04 | 4 | 186 | 2 | IPR012315 | |
| Domain | KASH | 5.84e-04 | 4 | 186 | 2 | PS51049 | |
| Domain | Peptidase_C54 | 5.84e-04 | 4 | 186 | 2 | PF03416 | |
| Domain | KASH | 5.84e-04 | 4 | 186 | 2 | SM01249 | |
| Domain | KASH | 5.84e-04 | 4 | 186 | 2 | PF10541 | |
| Domain | Peptidase_C54 | 5.84e-04 | 4 | 186 | 2 | IPR005078 | |
| Domain | aa-tRNA-synth_I_CS | 7.10e-04 | 18 | 186 | 3 | IPR001412 | |
| Domain | AA_TRNA_LIGASE_I | 8.37e-04 | 19 | 186 | 3 | PS00178 | |
| Domain | RNA_ligase/cNuc_Pdiesterase | 1.44e-03 | 6 | 186 | 2 | IPR009097 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.85e-05 | 121 | 141 | 8 | M872 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX SPTBN1 COPB2 KIF4A UNC45A GFPT1 PHLDB1 ATG4B UBN1 CIAO1 SERPINB12 CLTC PHIP HSPA8 BTRC CNP KPNA1 RARS1 RASA3 RTCB DSP UBR4 LARS1 NOL11 USP16 MACF1 PRKCD EXOC1 ATIC ZMYM3 | 2.57e-10 | 1353 | 200 | 30 | 29467282 |
| Pubmed | 1.22e-09 | 20 | 200 | 6 | 26694250 | ||
| Pubmed | 2.32e-09 | 22 | 200 | 6 | 31729367 | ||
| Pubmed | DNAJB12 USP9X COPB2 UNC45A PHLDB1 SYNE2 KLHL23 ZNHIT2 HSPA2 CEP97 HSPA8 CUL4B NUP98 TARS2 MAD2L1 | 3.64e-09 | 363 | 200 | 15 | 25036637 | |
| Pubmed | 5.42e-09 | 25 | 200 | 6 | 37451217 | ||
| Pubmed | SETX SPTBN1 UNC45A SERPINB12 CLTC HSPA8 KPNA1 WDR48 DSP UBR4 ZDBF2 RGS3 SMARCD1 | 7.41e-09 | 272 | 200 | 13 | 31010829 | |
| Pubmed | USP9X SPTBN1 COPB2 KIF4A GFPT1 SYNE2 CLTC HSPA2 PHIP CUL4B RTCB DSP UBR4 NUP98 NOL11 MTOR MACF1 ATIC ZMYM3 | 9.24e-09 | 653 | 200 | 19 | 22586326 | |
| Pubmed | 1.14e-08 | 28 | 200 | 6 | 25089626 | ||
| Pubmed | 4.74e-08 | 35 | 200 | 6 | 19389355 | ||
| Pubmed | RNGTT USP9X SPTBN1 SERPINB12 CLTC HSPA8 RARS1 KRT84 UBR4 NECAP2 PRKCD UBASH3B | 5.35e-08 | 266 | 200 | 12 | 19380743 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | USP9X SPTBN1 COPB2 UNC45A TTC3 GFPT1 TOMM70 SERPINB12 KLHL23 CLTC TAGLN2 TDRD6 PHIP HSPA8 RARS1 RTCB DSP SYNE1 UBR4 LARS1 NUP98 NOL11 TARS2 YARS1 MTOR PRKCD ATIC | 5.79e-08 | 1425 | 200 | 27 | 30948266 |
| Pubmed | TTC39B SPTBN1 COPB2 KIF4A UNC45A TOMM70 PHLDB1 SYNE2 ULK4 DMD PLEKHH2 KPNA1 RTCB DSP SYNE1 LARS1 NUDT13 YARS1 ROS1 | 8.88e-08 | 754 | 200 | 19 | 35906200 | |
| Pubmed | TTC39B USP9X GFPT1 TOMM70 FBXO3 SERPINB12 CLTC TAGLN2 DMD HSPA2 HSPA8 CNP KPNA1 CUL4B RARS1 DSP SYNE1 UBR4 YARS1 MACF1 | 1.08e-07 | 844 | 200 | 20 | 25963833 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DNAJB12 USP9X COPB2 UNC45A GFPT1 TOMM70 CLTC ZNHIT2 HSPA2 CEP97 RARS1 UBR4 LARS1 NUP98 DNAJC18 TARS2 URGCP MTOR SLC47A1 ATIC ZMYM3 | 1.41e-07 | 942 | 200 | 21 | 31073040 |
| Pubmed | SPTBN5 PHLDB1 SYNE2 DMD ZNHIT2 HSPA2 HSPA8 SYNE1 KRT84 PARP14 | 1.47e-07 | 187 | 200 | 10 | 26460568 | |
| Pubmed | SETX PRAMEF10 SPTBN1 COPB2 CD55 TTC3 CLTC NFRKB TSTD2 PRAMEF11 BRWD1 PRAMEF33 KRT84 PRAMEF15 NOL11 PRAMEF4 TBC1D31 MASTL MACF1 PRKCD ROCK1 CCDC171 | 3.45e-07 | 1084 | 200 | 22 | 11544199 | |
| Pubmed | SPTBN1 ZMYND8 UNC45A TTC3 ZNF518A THAP2 LDB1 ASCC2 FMNL1 KPNA1 PAPPA2 UBR4 RGS3 EPG5 MACF1 ROCK1 | 3.76e-07 | 591 | 200 | 16 | 15231748 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 4.70e-07 | 212 | 200 | 10 | 33853758 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | USP9X SPTBN1 COPB2 ZMYND8 KIF4A CLTC TAGLN2 HSPA8 RARS1 UBR4 LARS1 ZMYM3 | 5.79e-07 | 332 | 200 | 12 | 32786267 |
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 7.58e-07 | 30 | 200 | 5 | 38786026 | |
| Pubmed | RNGTT USP9X SPTBN1 COPB2 ITPR2 TOMM70 FBXO3 SYNE2 CLTC POC5 DMD HSPA2 BTRC KPNA1 WDR48 DSP NUP98 TARS2 TBC1D31 ROCK1 MAD2L1 | 8.07e-07 | 1049 | 200 | 21 | 27880917 | |
| Pubmed | ERAP1 ZNF518A PHLDB1 GPR158 SYNE2 WDR35 WDR48 CUL4B SYNE1 MACF1 | 8.09e-07 | 225 | 200 | 10 | 12168954 | |
| Pubmed | DNAJB12 USP9X SPTBN1 COPB2 UNC45A CLTC HSPA2 HSPA8 CNP CUL4B RARS1 UBR4 LARS1 NUP98 NOL11 MTOR | 1.03e-06 | 638 | 200 | 16 | 33239621 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | PRAMEF10 SPTBN1 CIAO1 WDR35 HSPA2 CEP97 HSPA8 PRAMEF11 DSP PRAMEF15 PRAMEF4 YARS1 MSR1 EXOC1 MAD2L1 | 1.10e-06 | 564 | 200 | 15 | 21565611 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | SPTBN1 COPB2 GFPT1 TOMM70 CLTC TAGLN2 HSPA2 HSPA8 RARS1 RTCB DSP SYNE1 UBR4 LARS1 EPG5 MASTL MACF1 ATIC | 1.14e-06 | 807 | 200 | 18 | 30575818 |
| Pubmed | USP9X SPTBN1 ZMYND8 TTC3 GFPT1 LDB1 CLTC HSPA2 BTRC KPNA1 BRWD1 DSP SYNE1 UBR4 LARS1 SEC31B USP16 YARS1 TXNDC11 MACF1 EXOC1 ATIC ZNF662 | 1.59e-06 | 1285 | 200 | 23 | 35914814 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 2.38e-06 | 17 | 200 | 4 | 23565261 | |
| Pubmed | 2.38e-06 | 17 | 200 | 4 | 37781892 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 3.05e-06 | 18 | 200 | 4 | 39181896 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 3.05e-06 | 18 | 200 | 4 | 29731491 | |
| Pubmed | 3.05e-06 | 18 | 200 | 4 | 14675769 | ||
| Pubmed | 3.05e-06 | 18 | 200 | 4 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 3.05e-06 | 18 | 200 | 4 | 12890732 | |
| Pubmed | Novel Cul3 binding proteins function to remodel E3 ligase complexes. | 3.34e-06 | 40 | 200 | 5 | 25011449 | |
| Pubmed | USP9X SPTBN1 KIF4A TTC3 HDAC3 LDB1 GPR158 SYNE2 CLTC HSPA8 CNP KPNA1 SYNE1 UBR4 MTOR MACF1 ROCK1 KIF4B UBASH3B | 3.42e-06 | 963 | 200 | 19 | 28671696 | |
| Pubmed | 3.70e-06 | 6 | 200 | 3 | 22696681 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 3.84e-06 | 19 | 200 | 4 | 28604677 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DNAJB12 RNGTT USP9X COPB2 UNC45A GFPT1 TOMM70 CLTC MED17 HSPA2 HSPA8 CNP KPNA1 WDR48 RARS1 RTCB DSP UBR4 LARS1 NOL11 TARS2 MAD2L1 | 3.89e-06 | 1257 | 200 | 22 | 37317656 |
| Pubmed | SPTBN1 COPB2 GFPT1 TOMM70 CLTC HSPA8 CNP RARS1 RTCB DSP UBR4 NUP98 NOL11 PARP14 YARS1 MACF1 | 4.11e-06 | 711 | 200 | 16 | 33022573 | |
| Pubmed | DNAJB12 ERAP1 USP9X KIF4A ITPR2 TOMM70 GRK2 PIK3C3 CLTC MED17 ALG6 HSPA2 HSPA8 FMNL1 CNP RARS1 UBR4 PARP14 MTOR EXOC1 ATIC | 4.34e-06 | 1168 | 200 | 21 | 19946888 | |
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 4.78e-06 | 20 | 200 | 4 | 21425410 | |
| Pubmed | 4.78e-06 | 20 | 200 | 4 | 16580637 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | DNAJB12 ERAP1 SPTBN1 COPB2 UNC45A GFPT1 SERPINB12 CLTC TAGLN2 HSPA8 RARS1 DSP UBR4 TARS2 MTOR | 5.82e-06 | 647 | 200 | 15 | 26618866 |
| Pubmed | 5.88e-06 | 21 | 200 | 4 | 37422473 | ||
| Pubmed | 6.08e-06 | 282 | 200 | 10 | 23667531 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | UNC45A ATXN7L3 ATG4B FBXO3 KLHL23 NFRKB OSBPL9 OSBPL10 TAGLN2 BTRC KPNA1 WDR48 CUL4B KRT84 NUP98 ICE1 USP16 GPN3 MAD2L1 | 6.29e-06 | 1005 | 200 | 19 | 19615732 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SETX RNGTT COPB2 EVPL DGKH GIMAP7 GFPT1 ITPR2 CLTC HSPA8 RARS1 DSP UBR4 ICE1 PARP14 ATIC | 6.34e-06 | 736 | 200 | 16 | 29676528 |
| Pubmed | KANSL1L SPTBN1 TTC3 TOMM70 SYNE2 CLTC HSPA8 DSP SYNE1 TEAD1 MACF1 EXOC1 PLCE1 | 6.95e-06 | 497 | 200 | 13 | 23414517 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DNAJB12 USP9X SPTBN1 COPB2 KIF4A UNC45A GFPT1 FBXO3 SYNE2 CLTC TAGLN2 ZNHIT2 HSPA8 CNP KPNA1 RARS1 RTCB DSP UBR4 LARS1 YARS1 MACF1 GPN3 | 7.74e-06 | 1415 | 200 | 23 | 28515276 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | USP9X ITPR2 PHLDB1 SERPINB12 SYNE2 CLTC TAGLN2 PHIP CNP RARS1 RTCB DSP SYNE1 KRT84 LARS1 NUP98 NOL11 MACF1 ATIC | 8.18e-06 | 1024 | 200 | 19 | 24711643 |
| Pubmed | 8.63e-06 | 23 | 200 | 4 | 19480014 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETX RNGTT USP9X UBN1 CIAO1 CLTC DSP ARHGAP17 ZDBF2 YARS1 PIKFYVE MACF1 ROCK1 ZMYM3 | 8.90e-06 | 588 | 200 | 14 | 38580884 |
| Pubmed | USP9X SPTBN1 COPB2 ITPR2 TOMM70 PHLDB1 NWD2 GRK2 SCN2A CLTC OSBPL9 OSBPL10 DMD HSPA2 HSPA8 CNP RTCB DSP SYNE1 LARS1 YARS1 MACF1 EXOC1 | 9.28e-06 | 1431 | 200 | 23 | 37142655 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 9.69e-06 | 235 | 200 | 9 | 28378594 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 1.03e-05 | 50 | 200 | 5 | 31806660 | |
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 1.22e-05 | 25 | 200 | 4 | 30309841 | |
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 1.22e-05 | 25 | 200 | 4 | 12620990 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | COPB2 KIF4A SERPINB12 CLTC POC5 TAGLN2 ZNHIT2 CEP97 KPNA1 CUL4B SYNE1 NUP98 TSEN54 HAUS2 MASTL SMARCD1 KIF4B ZMYM3 MAD2L1 MYBL1 | 1.28e-05 | 1155 | 200 | 20 | 20360068 |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 1.44e-05 | 26 | 200 | 4 | 18500982 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ERAP1 USP9X SPTBN1 COPB2 GFPT1 TOMM70 SERPINB12 SYNE2 CLTC OSBPL10 TAGLN2 HSPA8 CNP RTCB DSP UBR4 NUP98 MTOR ROCK1 EXOC1 ATIC MAD2L1 | 1.44e-05 | 1367 | 200 | 22 | 32687490 |
| Pubmed | USP9X COPB2 UNC45A TOMM70 ATG4B CLTC HSPA8 PLSCR4 CUL4B RARS1 RTCB DSP LARS1 YARS1 ATIC QRSL1 MAD2L1 | 1.45e-05 | 878 | 200 | 17 | 37223481 | |
| Pubmed | 1.46e-05 | 312 | 200 | 10 | 37120454 | ||
| Pubmed | USP9X COPB2 UNC45A GFPT1 TAGLN2 KPNA1 RARS1 RTCB UBR4 NUP98 TARS2 YARS1 MAD2L1 | 1.49e-05 | 534 | 200 | 13 | 35032548 | |
| Pubmed | Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. | 1.50e-05 | 54 | 200 | 5 | 31792442 | |
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 1.68e-05 | 27 | 200 | 4 | 18649358 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.91e-05 | 256 | 200 | 9 | 33397691 | |
| Pubmed | 1.92e-05 | 322 | 200 | 10 | 26514267 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.00e-05 | 197 | 200 | 8 | 20811636 | |
| Pubmed | DNAJB12 ERAP1 USP9X TOMM70 CLTC HSPA2 CNP KPNA1 WDR48 CUL4B UBR4 SMARCD1 MACF1 ATIC | 2.05e-05 | 634 | 200 | 14 | 34591612 | |
| Pubmed | USP9X SPTBN1 SERPINB12 CLTC HSPA8 CNP RARS1 RTCB DSP UBR4 LARS1 YARS1 ROCK1 | 2.06e-05 | 551 | 200 | 13 | 34728620 | |
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 2.14e-05 | 58 | 200 | 5 | 37117185 | |
| Pubmed | 2.18e-05 | 10 | 200 | 3 | 25578879 | ||
| Pubmed | A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. | 2.18e-05 | 10 | 200 | 3 | 18548008 | |
| Pubmed | USP9X DCUN1D4 GFPT1 THAP2 TBC1D32 PHLDB1 SYNE2 HERC6 MED17 KPNA1 UBR4 ZDBF2 SEC31B SMARCD1 | 2.20e-05 | 638 | 200 | 14 | 31182584 | |
| Pubmed | USP9X KIF4A CIAO1 CLTC BRWD1 RARS1 RTCB DSP UBR4 LARS1 SMARCD1 | 2.21e-05 | 399 | 200 | 11 | 37536630 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | USP9X SPTBN1 HDAC3 NWD2 GPR158 NFRKB TAGLN2 PHIP FMNL1 BTRC DSP UBR4 | 2.22e-05 | 475 | 200 | 12 | 31040226 |
| Pubmed | 2.25e-05 | 29 | 200 | 4 | 21834987 | ||
| Pubmed | SPTBN1 COPB2 SERPINB12 CLTC TAGLN2 HSPA8 CUL4B RARS1 RTCB DSP LARS1 NUP98 NOL11 TARS2 | 2.32e-05 | 641 | 200 | 14 | 36057605 | |
| Pubmed | 2.49e-05 | 332 | 200 | 10 | 37433992 | ||
| Pubmed | DNAJB12 KIF4A ITPR2 NFRKB POC5 CUL4B ARHGAP17 ICE1 ZDBF2 PIKFYVE NECAP2 TBC1D31 MASTL ROCK1 ATIC | 2.51e-05 | 733 | 200 | 15 | 34672954 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | SPTBN1 CLTC OSBPL9 TAGLN2 HSPA8 RASA3 DSP SYNE1 CCDC180 ZMYM3 | 2.55e-05 | 333 | 200 | 10 | 32665550 |
| Pubmed | DNAJB12 COPB2 ZMYND8 KIF4A UNC45A GFPT1 HDAC3 UBN1 MED17 CUL4B UBR4 NUP98 CASP1 NOL11 YARS1 SMARCD1 ATIC MAD2L1 | 2.56e-05 | 1014 | 200 | 18 | 32416067 | |
| Pubmed | TOMM70 PHLDB1 CLTC WDR48 SYNE1 HEATR5A EPG5 ACOT11 MACF1 ZMYM3 PLCE1 | 2.66e-05 | 407 | 200 | 11 | 12693553 | |
| Pubmed | 2.74e-05 | 61 | 200 | 5 | 20548051 | ||
| Pubmed | 2.74e-05 | 61 | 200 | 5 | 19875381 | ||
| Pubmed | 2.75e-05 | 150 | 200 | 7 | 32423001 | ||
| Pubmed | 2.86e-05 | 102 | 200 | 6 | 10231032 | ||
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 2.99e-05 | 271 | 200 | 9 | 25737280 | |
| Pubmed | 3.12e-05 | 153 | 200 | 7 | 27462432 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 3.29e-05 | 2 | 200 | 2 | 36482480 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 11792814 | ||
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 3.29e-05 | 2 | 200 | 2 | 30081192 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 19944437 | ||
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 3.29e-05 | 2 | 200 | 2 | 10559369 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 21565503 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 31262977 | ||
| Pubmed | Mechanistic Target of Rapamycin Regulates the Oligodendrocyte Cytoskeleton during Myelination. | 3.29e-05 | 2 | 200 | 2 | 32139584 | |
| Pubmed | The actions of exogenous leucine on mTOR signalling and amino acid transporters in human myotubes. | 3.29e-05 | 2 | 200 | 2 | 21702994 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 10773663 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 25619930 | ||
| Cytoband | 1p36.21 | PRAMEF25 PRAMEF10 PRAMEF9 PRAMEF11 PRAMEF33 PRAMEF15 PRAMEF4 | 1.21e-08 | 63 | 200 | 7 | 1p36.21 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF25 PRAMEF10 PRAMEF9 PRAMEF11 PRAMEF33 UBR4 PRAMEF15 PRAMEF4 NECAP2 MTOR PRAMEF27 PADI3 | 5.02e-05 | 681 | 200 | 12 | chr1p36 |
| Cytoband | 1q23-q25 | 1.13e-04 | 4 | 200 | 2 | 1q23-q25 | |
| GeneFamily | PRAME family | PRAMEF25 PRAMEF10 PRAMEF9 PRAMEF11 PRAMEF15 PRAMEF4 PRAMEF27 | 8.31e-10 | 24 | 153 | 7 | 686 |
| GeneFamily | EF-hand domain containing|Plakins | 3.23e-05 | 8 | 153 | 3 | 939 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.58e-05 | 206 | 153 | 9 | 682 | |
| GeneFamily | WD repeat domain containing | NBEAL1 COPB2 CIAO1 WDR35 PHIP BTRC BRWD1 WDR48 SEC31B TBC1D31 | 8.03e-05 | 262 | 153 | 10 | 362 |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 4.22e-04 | 4 | 153 | 2 | 1252 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 5.21e-04 | 19 | 153 | 3 | 131 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.45e-03 | 7 | 153 | 2 | 1113 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.46e-03 | 9 | 153 | 2 | 1203 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | TTC39B SPTBN1 GIMAP7 ITPR2 BEND6 SYNE2 WDR35 ULK4 CEP97 SELL RASA3 PARP8 LARS1 HEATR5A MACF1 INTS9 UBASH3B | 3.25e-07 | 507 | 197 | 17 | MM1030 |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | PRAMEF10 BCAR3 SLITRK6 PRAMEF11 PRAMEF33 PRAMEF15 PRAMEF4 FHDC1 | 7.80e-07 | 98 | 197 | 8 | MM3656 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | TTC39B SPTBN1 ITPR2 BEND6 SYNE2 WDR35 ULK4 CEP97 SELL RASA3 PARP8 LARS1 HEATR5A MACF1 INTS9 UBASH3B | 1.28e-06 | 498 | 197 | 16 | M1741 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | GPR155 SETX ERAP1 USP9X GIMAP7 ITPR2 GRK2 CIAO1 PHIP HSPA8 FMNL1 BRWD1 HTR7 SYNE1 PARP8 UBR4 NUP98 CASP1 TSEN54 ICE1 TRAPPC8 PARP14 EPG5 PIKFYVE CD4 MACF1 ROCK1 UBASH3B MYBL1 | 2.55e-06 | 1492 | 197 | 29 | M40023 |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | 2.65e-06 | 81 | 197 | 7 | MM938 | |
| Coexpression | DE_YY1_TARGETS_DN | 6.68e-06 | 93 | 197 | 7 | M3278 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SETX RNGTT USP9X ZMYND8 DCUN1D4 PIK3C3 SYNE2 BCAR3 DMD PHIP BTRC NUP98 TEAD1 TRAPPC8 PIKFYVE TBC1D31 MACF1 ROCK1 MYBL1 PLCE1 | 7.81e-06 | 856 | 197 | 20 | M4500 |
| Coexpression | GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN | 2.18e-05 | 200 | 197 | 9 | M7814 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN | 4.39e-05 | 169 | 197 | 8 | M379 | |
| Coexpression | GCNP_SHH_UP_LATE.V1_DN | 6.33e-05 | 178 | 197 | 8 | M2640 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ATG4A VAMP5 NBEAL1 USP9X CD55 DGKH ZNF518A THAP2 FBXO3 SLITRK6 PLSCR4 DSP ARHGAP17 HEATR5A PARP14 MACF1 ROCK1 PLCE1 | 8.55e-05 | 854 | 197 | 18 | M1533 |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 9.90e-05 | 98 | 197 | 6 | MM592 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PRAMEF10 NBEAL1 SLC22A23 SPTBN1 ZMYND8 ITPR2 PHLDB1 GLIS2 OSBPL9 WDR35 BTRC CNP PRAMEF11 SYNE1 PRAMEF15 NPC2 PRAMEF4 RGS3 MASTL UBASH3B MAD2L1 | 1.20e-04 | 1124 | 197 | 21 | MM1070 |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 1.20e-04 | 34 | 197 | 4 | MM955 | |
| Coexpression | GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP | 1.33e-04 | 198 | 197 | 8 | M3249 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP | 1.38e-04 | 199 | 197 | 8 | M8263 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN | 1.38e-04 | 199 | 197 | 8 | M8487 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 1.38e-04 | 199 | 197 | 8 | M6443 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN | 1.38e-04 | 199 | 197 | 8 | M6660 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.42e-04 | 200 | 197 | 8 | M9889 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 1.42e-04 | 200 | 197 | 8 | M7320 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN | 1.42e-04 | 200 | 197 | 8 | M8506 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN | 1.42e-04 | 200 | 197 | 8 | M6246 | |
| Coexpression | GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN | 1.42e-04 | 200 | 197 | 8 | M9020 | |
| Coexpression | GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP | 1.42e-04 | 200 | 197 | 8 | M3035 | |
| Coexpression | GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN | 1.42e-04 | 200 | 197 | 8 | M4338 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 1.57e-04 | 152 | 197 | 7 | M2964 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 1.84e-04 | 156 | 197 | 7 | MM550 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CD55 KIF4A DCUN1D4 HDAC3 SCN2A SYNE2 KLHL23 WDR35 SLITRK6 PLEKHH2 HSPA8 CUL4B PAPPA2 PNLIP RASA3 ZDBF2 MASTL PRKCD ZMYM3 MYBL1 PLCE1 | 8.96e-06 | 827 | 182 | 21 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.82e-07 | 188 | 199 | 9 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.70e-07 | 197 | 199 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.07e-07 | 200 | 199 | 9 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.07e-07 | 200 | 199 | 9 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.07e-07 | 200 | 199 | 9 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.01e-06 | 170 | 199 | 8 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 193 | 199 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 193 | 199 | 8 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.61e-06 | 193 | 199 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 2.82e-06 | 195 | 199 | 8 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 2.82e-06 | 195 | 199 | 8 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.82e-06 | 195 | 199 | 8 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.82e-06 | 195 | 199 | 8 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.92e-06 | 196 | 199 | 8 | e4c76e7ad68455e51fe93ce588bcec9383f8654b | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.04e-06 | 197 | 199 | 8 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.15e-06 | 198 | 199 | 8 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.40e-06 | 200 | 199 | 8 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.40e-06 | 200 | 199 | 8 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.40e-06 | 200 | 199 | 8 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.40e-06 | 200 | 199 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.40e-06 | 200 | 199 | 8 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.40e-06 | 200 | 199 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.40e-06 | 200 | 199 | 8 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.40e-06 | 200 | 199 | 8 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.17e-06 | 161 | 199 | 7 | f470b662566131dfe69a2fd01186ac8491196396 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Intermediate|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 9.63e-06 | 109 | 199 | 6 | 48f675d36fece070410eb9cfe64805f4629e290f | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.21e-05 | 171 | 199 | 7 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.41e-05 | 175 | 199 | 7 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.46e-05 | 176 | 199 | 7 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-05 | 177 | 199 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-05 | 177 | 199 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.51e-05 | 177 | 199 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.51e-05 | 177 | 199 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-05 | 177 | 199 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-05 | 182 | 199 | 7 | e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.94e-05 | 184 | 199 | 7 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | Healthy/Control-CD4+_CTL|Healthy/Control / Disease group and Cell class | 1.94e-05 | 184 | 199 | 7 | 6c6ffa150f81e456f88e9065de90c2dcda417589 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 185 | 199 | 7 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 185 | 199 | 7 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.16e-05 | 187 | 199 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.16e-05 | 187 | 199 | 7 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 188 | 199 | 7 | 1f07e3ab87173426fe0c429f5c084fb3425effd3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 188 | 199 | 7 | 85746f95319e494efdc1bbc24331698688d3a900 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.23e-05 | 188 | 199 | 7 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | HSPCs-Ery_prog.|HSPCs / Lineage and Cell class | 2.31e-05 | 189 | 199 | 7 | 37d2c45debed1564a40a1085b8b310c50923b9e7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 190 | 199 | 7 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 191 | 199 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 191 | 199 | 7 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 191 | 199 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-Treg|COVID-19_Severe / Disease group, lineage and cell class | 2.55e-05 | 192 | 199 | 7 | 3fb4c148dadcf5e79094e55c6bb53ec7bf9d44c8 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-05 | 192 | 199 | 7 | 7a90ec9fc8f29216c4828e0cf5d040906456e53b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.55e-05 | 192 | 199 | 7 | d883b91bbab71673de4858346d3ab33e5fbbf842 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.55e-05 | 192 | 199 | 7 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 193 | 199 | 7 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.64e-05 | 193 | 199 | 7 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.64e-05 | 193 | 199 | 7 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.64e-05 | 193 | 199 | 7 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 194 | 199 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.73e-05 | 194 | 199 | 7 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.73e-05 | 194 | 199 | 7 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.82e-05 | 195 | 199 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-05 | 195 | 199 | 7 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.82e-05 | 195 | 199 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.82e-05 | 195 | 199 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Mild-CD4+_T_activated|Mild / Disease group and Cell class | 2.91e-05 | 196 | 199 | 7 | daa1c3322d81e649161e889e1d78451d2d425d09 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.91e-05 | 196 | 199 | 7 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.91e-05 | 196 | 199 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 2.91e-05 | 196 | 199 | 7 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 2.91e-05 | 196 | 199 | 7 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.91e-05 | 196 | 199 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 2.91e-05 | 196 | 199 | 7 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-05 | 196 | 199 | 7 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-05 | 197 | 199 | 7 | 32b770e403028862f91e4727f4a8fbb6151910e4 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.01e-05 | 197 | 199 | 7 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.01e-05 | 197 | 199 | 7 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|World / disease group, cell group and cell class (v2) | 3.11e-05 | 198 | 199 | 7 | 7a0aac52d785037455e068e1b25de4b2bf0fff79 | |
| ToppCell | T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.11e-05 | 198 | 199 | 7 | 1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 198 | 199 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 198 | 199 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | severe_COVID-19-CD8+_Tem|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.11e-05 | 198 | 199 | 7 | 69d49f37cf5095e65c71cddc6d43748322ff19a3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.21e-05 | 199 | 199 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 3.21e-05 | 199 | 199 | 7 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.21e-05 | 199 | 199 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 199 | 199 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-05 | 199 | 199 | 7 | 0902b08e3386e64d7347c186d9ce5b67f2deaabb | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.21e-05 | 199 | 199 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-05 | 199 | 199 | 7 | 00ef3cc5c02639bfb839075ecf5f20026ff81f84 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 200 | 199 | 7 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 200 | 199 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.31e-05 | 200 | 199 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.31e-05 | 200 | 199 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Control-Control-Lymphocyte-T/NK|Control / Disease, condition lineage and cell class | 3.31e-05 | 200 | 199 | 7 | 6a399d9fa005547e5fadd3c0dafd7e4381732460 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-Treg|COVID-19_Severe / Disease, condition lineage and cell class | 3.31e-05 | 200 | 199 | 7 | 2b363f2a1d08019b6ff0b10419870049063cc1cf | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 3.31e-05 | 200 | 199 | 7 | b7f80b2db07119069fbf3d245cf1ad79e8648bab | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK|URO / Disease, condition lineage and cell class | 3.31e-05 | 200 | 199 | 7 | ef40ed94261bdb79b7bde4196ff08bf327717b6b | |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.31e-05 | 200 | 199 | 7 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-Treg|Multiple_Sclerosis / Disease, condition lineage and cell class | 3.31e-05 | 200 | 199 | 7 | 8702758a62fa923c2e9012c0aa8b3b492a44f8fb | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 200 | 199 | 7 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.31e-05 | 200 | 199 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 142 | 199 | 6 | a88bf4bcc80206b16dcc504cc19a3380d01e34a4 | |
| Drug | plakin | 3.08e-08 | 82 | 192 | 9 | CID000018752 | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | DNAJB12 KANSL1L ZMYND8 ITPR2 LDB1 NFRKB HSPA2 BTRC CNP WDR48 NUP98 | 8.72e-07 | 195 | 192 | 11 | 5004_DN |
| Drug | monastrol; Up 200; 100uM; PC3; HG-U133A | DNAJB12 RNGTT PHLDB1 LDB1 SCNN1A OSBPL9 DMD CASP1 RGS3 PLCE1 | 7.40e-06 | 198 | 192 | 10 | 668_UP |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.38e-04 | 4 | 187 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 3.95e-04 | 5 | 187 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 3.95e-04 | 5 | 187 | 2 | C0410190 | |
| Disease | Duchenne and Becker Muscular Dystrophy | 3.95e-04 | 5 | 187 | 2 | C3542021 | |
| Disease | Becker Muscular Dystrophy | 3.95e-04 | 5 | 187 | 2 | C0917713 | |
| Disease | Emery-Dreifuss muscular dystrophy | 5.89e-04 | 6 | 187 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 5.89e-04 | 6 | 187 | 2 | C0410189 | |
| Disease | Muscular Dystrophy, Duchenne | 5.89e-04 | 6 | 187 | 2 | C0013264 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 8.22e-04 | 7 | 187 | 2 | C0751337 | |
| Disease | Large cell carcinoma of lung | 1.09e-03 | 32 | 187 | 3 | C0345958 | |
| Disease | Malignant neoplasm of breast | TTC3 SYNE2 BCAR3 DMD ZNHIT2 SYNE1 UBR4 NUP98 TRAPPC8 EPG5 MTOR ANKRD30A SMARCD1 MACF1 ZFYVE26 PADI3 | 1.41e-03 | 1074 | 187 | 16 | C0006142 |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.74e-03 | 10 | 187 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.74e-03 | 10 | 187 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | congestive heart failure (is_marker_for) | 1.86e-03 | 82 | 187 | 4 | DOID:6000 (is_marker_for) | |
| Disease | Intellectual Disability | 2.30e-03 | 447 | 187 | 9 | C3714756 | |
| Disease | descending aortic diameter | 2.41e-03 | 88 | 187 | 4 | EFO_0021788 | |
| Disease | Kidney Diseases | 2.41e-03 | 88 | 187 | 4 | C0022658 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.53e-03 | 12 | 187 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.53e-03 | 12 | 187 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | revision of total hip arthroplasty | 3.46e-03 | 14 | 187 | 2 | EFO_0020973 | |
| Disease | epilepsy (implicated_via_orthology) | 3.90e-03 | 163 | 187 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 3.97e-03 | 15 | 187 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | pathological myopia | 5.52e-03 | 111 | 187 | 4 | EFO_0004207 | |
| Disease | Feeding difficulties | 5.72e-03 | 18 | 187 | 2 | C0232466 | |
| Disease | brain aneurysm | 5.88e-03 | 113 | 187 | 4 | EFO_0003870 | |
| Disease | hair colour measurement | DNAJB12 SLC22A23 SYNE2 BCAR3 RASA3 PARP8 RGS3 EPG5 CCDC171 PADI3 | 6.08e-03 | 615 | 187 | 10 | EFO_0007822 |
| Disease | hemoglobin A1 measurement | GPR155 SLC22A23 DCUN1D4 SYNE2 ASCC2 RARS1 MACF1 RGS17 UBASH3B | 6.15e-03 | 520 | 187 | 9 | EFO_0007629 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIQELEVWKKCSLNK | 206 | A0A0G2JMD5 | |
| AICIYWINNLQKEKK | 261 | Q96KV6 | |
| ASQCTLREKNKWQKE | 326 | Q96MC4 | |
| SDCQNAKSRLWQFKE | 316 | Q9HCE0 | |
| VINKDQWCNVLEFSR | 246 | Q92564 | |
| EQRNKNCTAIWEAFK | 61 | Q10588 | |
| DNWCSLVQKEILKEN | 331 | Q8WYN0 | |
| SQLENQKAKWEQELC | 996 | Q9BXX2 | |
| QKAKWEQELCSVRLT | 1001 | Q9BXX2 | |
| KISDKQTEWIENCQR | 936 | Q96NH3 | |
| FVLTCQWKNLAQHFK | 186 | O75815 | |
| ANIWCSFNVFLKIKD | 276 | Q9Y672 | |
| FQWVSLCVTELKNNV | 276 | A1IGU5 | |
| VKIWDYQNKTCVQTL | 211 | P35606 | |
| KFWCQVIFDETLQKC | 76 | Q9H1I8 | |
| EKAFQTSQQKWKEEC | 131 | Q6TFL3 | |
| LQNVLHCWEKEKAQA | 531 | Q6TFL3 | |
| FTKVAEQIKAQESCW | 646 | Q6TFL3 | |
| QESCWHRQKKELELQ | 656 | Q6TFL3 | |
| WNAVEKLCAKSANAI | 341 | Q96GX5 | |
| RDNTIKIWDKNTLEC | 321 | Q9Y297 | |
| SQLENQKVKWEQELC | 1011 | Q9BXX3 | |
| SEKQWNVCKALATFV | 136 | Q8WXI4 | |
| FVCWRKIKQSCEEEN | 486 | Q5ZPR3 | |
| NFARCWDNLVQKLEK | 646 | P11532 | |
| VQNCKKQLLDWKAFT | 456 | Q9P1Z9 | |
| QNWKNEQALVVCKQL | 396 | Q9NR16 | |
| AFCQWFVKEILQNHK | 116 | Q8IVL8 | |
| IFGQVFNQWKSKECV | 71 | Q14CW9 | |
| EDDFNDWCQQVKKLS | 326 | Q9Y4P1 | |
| EKQFQIEKWQIARCN | 171 | Q5SZJ8 | |
| IESDKFTRFCQWKNV | 166 | P25098 | |
| SIEQLFWSLEKKCGQ | 641 | Q9ULI1 | |
| GNKVVNWDIKDIINC | 856 | Q6ZS30 | |
| KDWIDILTKVSQCNQ | 666 | Q14644 | |
| LVDNKCFVLQLWDTA | 876 | Q7Z6P3 | |
| LLFWLACEDLKKEQN | 111 | Q9UGC6 | |
| QEQKKRVCWCLSENI | 651 | P49796 | |
| QIFAEWLCHNKQSKV | 341 | Q9NV88 | |
| CKEVNAVNCNTSWKI | 206 | Q14571 | |
| ECFNKKIQFNAHIWT | 511 | Q96SU4 | |
| AASKECLSVWNIKFQ | 281 | Q9H8H0 | |
| VEWQLQDDKNQSLFC | 126 | P61916 | |
| QFAIEKLRELECWKQ | 406 | Q9C0D6 | |
| VVQKQWKDVVERACQ | 291 | Q8NA72 | |
| SEKKQINVCSQLDWK | 1411 | P52948 | |
| FVTQQWKQSKEKSNC | 251 | Q8N3A8 | |
| TNVDKVQLQNCKWYQ | 161 | A0AUZ9 | |
| KLLETKWSFLQEQKC | 191 | Q9NSB2 | |
| KWSFLQEQKCIRSNL | 196 | Q9NSB2 | |
| NILKWRKQQNEVSSC | 186 | Q9NVX0 | |
| NNVVEQLKDWLYKCS | 66 | Q13257 | |
| IFELNKRLQNWTEEC | 71 | Q86U70 | |
| QLWLETKDQAFCKQE | 476 | Q6P4R8 | |
| DNKIIECKFENNSWV | 511 | O60942 | |
| KIWEGSSKCNINNFI | 336 | Q05655 | |
| NWLANVCKNLFKVES | 101 | P16233 | |
| IFCEIQKWKDTQNAS | 186 | Q7Z3F1 | |
| SNQKRIDKAEVCLWE | 1061 | Q5T848 | |
| KIAAQSEEWSCVLNK | 126 | Q5T1J6 | |
| DKTIVECLKNVNKCW | 36 | P0C7L1 | |
| FTKAQRKNISVWCKQ | 351 | Q16206 | |
| LQNLKWSTAVEFCKK | 146 | P08174 | |
| CRTQNKEKLQWLLDE | 806 | Q9NZ08 | |
| EEKTQKNQCWKSLFI | 66 | Q9UK99 | |
| NKILDKCQEVINWLD | 571 | P54652 | |
| WNLCRAVYSIQNEKK | 226 | Q9NRQ2 | |
| QRDKWELLQNFTCLD | 56 | Q96T54 | |
| QNWDTLLFCIQEGVK | 331 | Q9UHC1 | |
| DWARVLEQKQKQVCA | 151 | Q92817 | |
| EEVLKNCEIVNWKQR | 86 | Q969I3 | |
| NWKNLVVPFAKAVCE | 496 | Q8IVU3 | |
| LQVLKKCWAFLQESS | 516 | Q8IVU3 | |
| KALANCKEWQEQSII | 101 | Q9BS92 | |
| KLQVLDLQDVCENFW | 101 | P0DUQ1 | |
| LFQISNKLWCKSSQV | 71 | P00709 | |
| KCQSTQRDLWNIFKL | 6 | P14151 | |
| TNLCKFTKWIQETIQ | 276 | Q9Y337 | |
| WQTKLEAAQNVLLCK | 291 | Q9NVC6 | |
| KQLVCRWAKCNQLFE | 166 | Q9BZE0 | |
| NKFVQSCIDWNREVL | 541 | Q9ULW8 | |
| WVLSEIDKLNLNKQC | 396 | Q86XP1 | |
| QLIKEWVEKQTCSSL | 336 | Q86X67 | |
| TQLNNKICDIAINWA | 116 | O15379 | |
| QGNIKICDIISKWEQ | 1181 | Q8IVE3 | |
| KCRQSFEAWQEKQKE | 166 | Q96JM4 | |
| RTWLDDKQSQQAKNC | 4811 | Q9UPN3 | |
| VAAQLLKWETKNCSV | 71 | P21757 | |
| KLACADTWLNQVVIF | 186 | Q96R48 | |
| VLCKNGDDRQQWTKT | 491 | Q96FL9 | |
| LQQVNWKEFSKCLFI | 546 | Q460N5 | |
| EGLWTQEFKLCENLQ | 1636 | Q9BXP8 | |
| IAKKQSLCEVLQAWN | 1491 | Q9Y2I7 | |
| EVLNCLRAFLNWEKN | 2061 | Q9Y2F5 | |
| AQLAAVKDICQAIWK | 371 | Q86XA9 | |
| FKTWKESQRDCTQLQ | 96 | D3W0D1 | |
| ILCSKFKEVWQQEEF | 161 | Q8NBE8 | |
| KQLVQQLEQWEFRVC | 121 | Q9UHW5 | |
| LCWIQDEIVLQVFSK | 11 | A0A1B0GVN3 | |
| CSLEEAQRIWKQKSA | 136 | P29466 | |
| AFCDQQLLTVAKWFE | 481 | Q9H0R6 | |
| QKLNDAATKLQACWR | 556 | Q8IW35 | |
| YIANLRNNCWKEKQQ | 321 | Q9NXW2 | |
| QLQKARQCEKENLGW | 1141 | P15924 | |
| TWTCTVLQNQKKVEF | 181 | P01730 | |
| LDCAQLKEKNQWQLS | 156 | P09543 | |
| DVTFNIICKKCGWNI | 356 | P29320 | |
| SNWKKQCKELVNLIF | 1316 | Q9NSI6 | |
| NEKKWELICDQERFQ | 61 | O95466 | |
| CWKEKQQKSELTNLA | 311 | Q9H819 | |
| KQRWENIATILEAKC | 851 | O95239 | |
| KQCWENIATILEAKC | 851 | Q2VIQ3 | |
| AEKNAFISCIWKLNQ | 106 | Q9NV70 | |
| QQAVDETKKKQWCAN | 1016 | Q9ULU4 | |
| DWKIGFQLCNQNKSD | 221 | P37088 | |
| DSVLFLKKIDRCWQN | 281 | Q13620 | |
| KVVKLEKNLQSNCEW | 701 | P10243 | |
| DKQKILDKCNEIINW | 566 | P11142 | |
| LDKCNEIINWLDKNQ | 571 | P11142 | |
| DQVCQWVLKCRNSKN | 371 | P42345 | |
| NDELQFLEKINKNCW | 6 | Q9Y3I0 | |
| QDIKNVCLELTIWDK | 651 | Q8TDW5 | |
| CLWDQAEQVLKQALK | 506 | Q9BW92 | |
| KAWKLICDVSRQELN | 306 | P54136 | |
| CWKTEAQNLKARQQL | 161 | Q3SY00 | |
| QAKQIWKCLAENAVY | 676 | Q93008 | |
| KISEECIAQWKQTNF | 496 | P54577 | |
| VEKCYQQKDWQRLLL | 56 | Q8TEB9 | |
| DNAWQKNLELKCTIF | 911 | O60522 | |
| LAKAEQACLNTDWQI | 886 | Q96DN5 | |
| ETDAESWCQKLNQRK | 331 | Q7Z6J9 | |
| EDNKWACNCDLLQLK | 216 | Q9H5Y7 | |
| FINDWLQSQCRDLKT | 451 | Q96GM5 | |
| FQQWLVNAKITTAKC | 3076 | Q8NF91 | |
| VQCLKTWFETQEKRL | 7031 | Q8NF91 | |
| QAEQEDTQKKAFTCW | 26 | Q8WXH0 | |
| DTQKKAFTCWINSQL | 31 | Q8WXH0 | |
| CKTQVAELELWLQQA | 4241 | Q8WXH0 | |
| LNTWVVFNEKNKELC | 5916 | Q8WXH0 | |
| VFNEKNKELCAWLVQ | 5921 | Q8WXH0 | |
| NFQNWLKDGTVLCEL | 51 | P37802 | |
| NDKDWEANACKIQLI | 46 | Q06210 | |
| VLLDQECVFQAQSKW | 2211 | Q9P212 | |
| QDQDKKLQDLWRTCQ | 351 | Q68EM7 | |
| EENWKKQTSQCLKNL | 536 | Q9P2J5 | |
| LVQNVVSKWDLVCDN | 211 | A1A5C7 | |
| KRKENCTLQFESAWV | 136 | P52294 | |
| ANVEEQCEWLIKSKI | 911 | Q9Y2K3 | |
| QAVTKNCQKASREWQ | 41 | Q8NHV1 | |
| QEKALTKFLKCVNWD | 326 | Q8NEB9 | |
| KLQVLDLQDVCENFW | 101 | A6NGN4 | |
| SSQQWVEAVVKCAKL | 481 | Q7Z333 | |
| KLQVLDLQDVCENFW | 101 | A3QJZ7 | |
| KFCALNWKEQSAVVL | 76 | Q15493 | |
| SLLACVVQKNWKDVV | 621 | Q9NQW1 | |
| VVQKNWKDVVCTCSL | 626 | Q9NQW1 | |
| LDLKKNVVRVWFCNQ | 311 | Q15319 | |
| AKEKQFWVTQLRACA | 156 | Q9BXB5 | |
| KEVFWDVLQKNLCFS | 296 | A6NF89 | |
| WVECQSQGKIKELFS | 161 | Q96P63 | |
| FIIQLNWKKACQQAQ | 456 | Q96FL8 | |
| QEKTFTKWINNVFQC | 56 | Q9NRC6 | |
| DLQKFLQDCQELSLW | 1276 | Q01082 | |
| WAQNVNDDKVCLISQ | 221 | P34969 | |
| CIWKKNQDDFECVTT | 86 | O76071 | |
| CQIINYRTDAKQKWL | 151 | Q00610 | |
| KLQVLDLQDVCENFW | 101 | O60810 | |
| KECIKFWAQTNTNDT | 681 | Q8ND24 | |
| WRKAAQVEKEFCQLQ | 501 | Q8TCY9 | |
| FQKCISVQEEWKQFH | 416 | Q5VTQ0 | |
| NNNVAYWDVLKACKV | 381 | Q8TAF3 | |
| LKKALVNVEWNICQD | 36 | Q9Y5T5 | |
| WKKQCEELLNLIFQC | 1321 | Q8WWQ0 | |
| QKKWNIFDCIIVTVS | 726 | Q9Y5Y9 | |
| KLQVLDLQDVCENFW | 101 | P0DUQ2 | |
| CKALIESNQTARWKN | 1386 | Q99250 | |
| LVFNKTAFWEQKCSV | 346 | Q9HCK1 | |
| DWALQANIKAQKLCK | 316 | P53804 | |
| FNKTTQNLAQKKCWE | 51 | O95183 | |
| SIQELEVWKKCSLNK | 206 | O60809 | |
| KLQVLDLQDVCENFW | 101 | O60813 | |
| LQKWKEVAQDCTKAV | 166 | O94826 | |
| KCCNKNEVVVEFRWN | 1056 | P08922 | |
| EKLWKCCRQLFTDQT | 76 | Q5T7W7 | |
| NENQNLECATEKSKW | 736 | Q6AHZ1 | |
| KQKAAAEAQCQWDAL | 1056 | Q86UU1 | |
| CDALNAWQLVKELKE | 241 | P31939 | |
| LLLACSQDEQKKWVT | 1296 | Q13464 | |
| CFLNSEVQCELKRKW | 376 | P41587 | |
| ENICKWALENQETLF | 341 | Q6PKC3 | |
| ARKKCQFLLAWTNEN | 336 | Q9UHR6 | |
| KKFQWNDEIRELLCQ | 511 | Q9NPG3 | |
| LERNNKAQAWEDCVK | 536 | Q9NPG3 | |
| SLWEKVCENQRNLNV | 146 | C9J1S8 | |
| WAINDIIRNFCKDVV | 116 | P36537 | |
| DTCVWDSKVENQQKK | 41 | Q8NB50 | |
| QKCSEVDLNIVILWK | 1231 | Q9Y2L5 | |
| LLLSEDCFQAKQWKN | 141 | Q53H54 | |
| SWNIQNNDLKCKIIT | 76 | Q8TDU5 | |
| WIKATCLVKNLEANS | 166 | Q9H0W7 | |
| AQKLSDFWQQSKQIC | 101 | Q8TF42 | |
| VNKVWVQCENENCLK | 26 | Q504Y3 | |
| FLVKFWADLNCNIQD | 286 | P28347 | |
| ELVAELCSQKQKVWD | 46 | Q9H521 | |
| FDTNAEGCILQWKKI | 31 | O96006 | |
| LCWVSGQQKEKSDQQ | 16 | A0A075B6W5 | |
| KLQCVSWNKEQGFIA | 16 | Q9P2L0 | |
| RTINWQKFCIKDDSV | 3286 | Q5T4S7 | |
| QCQLWKTCKQLLETA | 981 | Q68DK2 | |
| LAKQCRKWLCNDQID | 526 | Q9H3U1 | |
| CKKEIWNTKDSVVAQ | 356 | Q14202 | |
| QECAKAFVWKSNLIR | 251 | Q6ZS27 | |
| LKDQDWNDFLQQVCS | 456 | Q96C45 | |
| TCLEQNKEAWNIKRN | 66 | A0A1W2PQL4 | |
| ALQDHFKWVKQQCEF | 121 | Q9NVZ3 |